CLINICAL NEWS

Majority of emergency department visits are due to adverse drug reactions, study finds

A surprisingly few medication classes are responsible for the majority of emergency department visits due to adverse drug reactions among U.S. adults aged 65 years and older, according to a study published in the November 24 issue of the New England Journal of Medicine. » More

Statins show benefits years after treatment stops

Long-term statin use is safe and effective, and it may continue to produce benefits without serious side effects years after patients stop taking the drugs, according to a study published online November 23 in The Lancet. » More

Abciximab-heparin combination treatment is no more effective than bivalirudin, study finds

Abciximab plus unfractionated heparin was no more effective than bivalirudin at reducing risk of death or other events for patients with non–ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention, according to a study published online November 24 in the New England Journal of Medicine. » More

CONTINUING EDUCATION

Pre-diabetes and type 2 diabetes management

With 25.8 million Americans diagnosed with diabetes and an estimated 79 million more pre-diabetic, every pharmacist must be able to counsel patients and monitor progression. Earn up to 2 CPE credits. » Click here to login and take the exams.

FDA ACTIONS

First generic version of cholesterol-lowering Lipitor approved

FDA approved the first generic version of the cholesterol-lowering drug Lipitor (atorvastatin calcium tablets), and Ranbaxy Laboratories has gained approval to make generic atorvastatin calcium tablets in 10-mg, 20-mg, 40-mg, and 80-mg strengths. » More

HEALTH INFORMATION TECHNOLOGY

The Joint Commission says texting orders is not appropriate

The Joint Commission recently issued a statement stating that it is not acceptable to text orders for patients to the hospital or other healthcare setting. The statement was in response to a question recently posed on the organization’s website. » More

TECHNOLOGY

AMA launches medical information app

The American Medical Association has launched its second electronic application, “My Medications.” » More

Confirm your
e-newsletter subscription click here.

To ensure future delivery of email newsletters from Drug Topics please take a moment to confirm your subscription by clicking here.
Thank you,
Drug Topics Staff

Voices

•	Anticoagulation update
•	JP at Large
•	View from the Zoo
•	Viewpoints
•	Regulatory & Legal

Meetings & Events

Digital Edition

•	View current edition

You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, Click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 866-529-2922 at any time, or fax us at 218-740-6417. Outside the U.S., please phone 218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.